[Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
The efficacy of medical treatment of peripheral obliterating arteriopathies on an aetiopathogenetic basis in the light of diabetes and atherosclerosis is discussed. The pros and cons of management with vasoactive drugs exercising a dilatatory action of choice on the metarterioles and the arteriolocapillary sphincters are summarised, together with the possibilities offered by such drugs. A example of the short-term effects of chorionic gonadotrophin in atherosclerotic forms is presented. Such effects include the improvement of arteriolocapillary flow and the correction of dyslipidaemia. It is suggested that chorionic gonadotrophin can be successfully associated in consecutive courses with vasoactive drugs and anticoagulants to obtain long-term success, even in cases treated for ten years.
D001162:Arteriosclerosis Obliterans / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D001775:Blood Circulation; D002784:Cholesterol / Q000097:blood; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D006801:Humans; D007457:Iodine Radioisotopes; D007866:Leg / Q000098:blood supply*; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D010992:Plethysmography, Impedance; D011516:Prothrombin; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D006063:Chorionic Gonadotropin; D007457:Iodine Radioisotopes; D009539:Nicotinic Acids; D046948:Secologanin Tryptamine Alkaloids; D014665:Vasodilator Agents; D011516:Prothrombin; D002784:Cholesterol
In tema di terapia medica delle arteriopatie obliteranti periferiche specie aterosclerotiche